ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,775Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 103

$756K Total Retail Price of All Prescriptions

Rank: 10 out of 103

512 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 512 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 512 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,056 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 637 556 1 3
SIMVASTATIN 539 462 2 2
LISINOPRIL 516 412 3 5
LEVOTHYROXINE SODIUM 484 434 4 1
AMLODIPINE BESYLATE 433 406 5 6
FUROSEMIDE 407 358 6 4
METOPROLOL TARTRATE 388 354 7 9
WARFARIN SODIUM 382 354 8 7
HYDROCHLOROTHIAZIDE 359 312 9 16
CITALOPRAM HBR 302 285 10 15
HYDROCODONE-ACETAMINOPHEN 301 264 S3 11 11
DONEPEZIL HCL 290 278 12 28
TRAMADOL HCL 288 267 13 17
METFORMIN HCL 219 188 14 13
LOSARTAN POTASSIUM 211 210 15 12
SERTRALINE HCL 206 198 16 21
ALENDRONATE SODIUM 195 195 17 19
POTASSIUM CHLORIDE 190 168 18 10
ZOLPIDEM TARTRATE 181 167 19 29
ATORVASTATIN CALCIUM 176 151 20 18
GABAPENTIN 165 116 21 22
METOPROLOL SUCCINATE 162 139 22 8
ATENOLOL 148 127 23 14
MIRTAZAPINE 134 119 24 36
CARVEDILOL 130 124 25 20
DIGOXIN 124 113 26 25
SPIRONOLACTONE 120 94 27 30
NAMENDA 116 116 28 41
DIOVAN 110 110 29 40
GLIMEPIRIDE 109 109 30 50
PRAVASTATIN SODIUM 107 103 31 33
GEMFIBROZIL 100 100 32 62
CRESTOR 99 90 33 27
TAMSULOSIN HCL 97 97 34 23
CLOPIDOGREL 97 83 34 32
KLOR-CON M20 92 73 36 56
POLYETHYLENE GLYCOL 3350 85 69 37 31
CYMBALTA 83 53 38 60
ALLOPURINOL 81 79 39 26
PLAVIX 80 72 40 46
PREDNISONE 80 80 40 24
ENALAPRIL MALEATE 79 79 42 63
DILTIAZEM 24HR CD 77 60 43 61
HUMULIN N 77 72 43 163
CARBIDOPA-LEVODOPA 75 50 45 55
FENOFIBRATE 75 51 45 58
LANTUS 74 61 47 39
FENTANYL 68 68 S2 48 34
TRIAMTERENE-HCTZ 66 63 49 38
VESICARE 66 58 49 105
KLOR-CON 10 60 60 51 45
OXYBUTYNIN CHLORIDE ER 60 55 51 74
ADVAIR DISKUS 56 39 53 42
NOVOLOG 52 52 54 94
FLUTICASONE PROPIONATE 51 45 55 35
VENTOLIN HFA 51 51 55 141
BUPROPION XL 50 44 57 180
CHLORTHALIDONE 50 48 57 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.